MRAs、SGLT2抑制剂与CKD和HF的肾脏预后:疾病、药物或两者的差异?

IF 10.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Luís Mendonça MD , João Sérgio Neves MD, PhD , Jeffrey Testani MD , Faiez Zannad MD, PhD , João Pedro Ferreira MD, PhD
{"title":"MRAs、SGLT2抑制剂与CKD和HF的肾脏预后:疾病、药物或两者的差异?","authors":"Luís Mendonça MD , João Sérgio Neves MD, PhD , Jeffrey Testani MD , Faiez Zannad MD, PhD , João Pedro Ferreira MD, PhD","doi":"10.1016/j.jchf.2025.102514","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 8","pages":"Article 102514"},"PeriodicalIF":10.3000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MRAs, SGLT2 Inhibitors, and Kidney Outcomes in CKD and HF\",\"authors\":\"Luís Mendonça MD , João Sérgio Neves MD, PhD , Jeffrey Testani MD , Faiez Zannad MD, PhD , João Pedro Ferreira MD, PhD\",\"doi\":\"10.1016/j.jchf.2025.102514\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14687,\"journal\":{\"name\":\"JACC. Heart failure\",\"volume\":\"13 8\",\"pages\":\"Article 102514\"},\"PeriodicalIF\":10.3000,\"publicationDate\":\"2025-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Heart failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221317792500441X\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221317792500441X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
MRAs, SGLT2 Inhibitors, and Kidney Outcomes in CKD and HF
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC. Heart failure
JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
21.20
自引率
2.30%
发文量
164
期刊介绍: JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信